Chen et al. suggested that LPAR2 (EDG4) and LPAR1 (EDG2) could cooperatively promote an efficient Rho-dependent chemotaxis in breast carcinoma cells, while they observed LPA2 to be less efficacious [27]. This evidence concerns the gene LPAR2 and breast carcinoma.